PR Newswire November 6, 2026 neutral

CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London

Edge AI

<p>Discussions will highlight progress from CREATE's four clinical-stage in vivo CAR programs across autoimmune disease and oncology CAMBRIDGE, Mass., Nov. 6, 2026 /PRNewswire/ -- CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo multi-immune...</p>

Read original article ↗

Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform

Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-p

PR Newswire · November 6, 2026

Společně za městskou budoucnost poháněnou umělou inteligencí: Dahua Technology představila na veletrhu SCEWC 2026 praktická řešení v oblasti AIoT

BARCELONA, Španělsko, 6. listopadu 2026 /PRNewswire/ -- Společnost Dahua Technology, přední světový poskytovatel řešení

PR Newswire · November 6, 2026

Cavli Wireless to Unveil P16QS LTE Cat 1bis Module and Cortex AI Coding Assistant at electronica 2026

MUNICH, Nov. 6, 2026 /PRNewswire/ -- Cavli Wireless, a leading end-to-end IoT solutions provider, will unveil the P16QS

PR Newswire · November 6, 2026

Samen voor een door AI aangedreven stedelijke toekomst: Dahua Technology presenteert praktische AIoT-oplossingen op SCEWC 2026.

BARCELONA, Spanje, 6 november 2026 /PRNewswire/ -- Dahua Technology, een wereldwijd toonaangevende aanbieder van op vide

PR Newswire · November 6, 2026

CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London

Related Articles